Cystatin C (recombinant)

Added to your cart

Cystatin C (recombinant)

Cart subtotal: £0.00

View cart (0) Checkout

#SKU P713-1


Price excludes shipping costs.
To view our shipping costs click here.

Need to order this product in bulk?

Contact our team of experts to discuss your bulk requirements

Contact our expert team

Product Details

Cystatin C is most widely used as a diagnostic marker for kidney function. Routine kidney function tests measure serum Creatinine, Urea and Glomular Filtration Rate (GFR). Serum Cystatin C is measured as part of measuring GRF, as it is quicker and easier than traditional techniques of collecting urine samples over a 24 hour period. It has been shown to not be affected by age, gender and body weight. Eliminates potential interferences from other proteins or contaminants due to high purity and low bioburden. Demonstrates excellent recovery compared to native Cystatin C. Ensure supply sustainability with a product not dependent on a biological raw material


More information



  • Shipping Information
  • Cool Pack
  • Abbreviations
  • Cys C
  • Specification
  • >96%
  • Recommended Use
  • Research and further manufacturing
  • Storage
  • Below -15°C
  • Buffer
  • lyophilised from 0.02M NH4HCO3
  • Presentation Matrix
  • Single homogenous batch, supplied lyophilised from 0.02M NH4HCO3. May contain traces of buffer salts
  • Purity/grade
  • >96%
  • Source
  • Expressed in P. pastoris
  • Applications
  • Clinical Chemistry, Control Manufacture, ELISA, Lateral Flow, Life Science
  • Molecular weight
  • 13.3kDa

Technical Documents

Certificates Of Analysis (90.01KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox